DynaMedex® Earns 2026 KLAS Recognition for Clinical Decision Support Excellence

In a significant milestone for the healthcare technology sector, DynaMedex®, an integrated clinical decision support solution produced by EBSCO Information Services and Micromedex by Merative, has been named the best performing tool in the 2026 KLAS Software and Services Report. This accolade marks the sixth time that EBSCO Information Services has received such a prestigious honor, underscoring the company's unwavering dedication to enhancing point-of-care decision-making in the healthcare landscape.

The Essence of DynaMedex

DynaMedex is not just a standalone tool, but a fusion of two industry-leading platforms—DynaMed and Micromedex. This integration offers healthcare professionals timely access to peer-reviewed disease guidance and evidence-based drug information, a combination that is critical in improving patient outcomes. With KLAS naming DynaMed in its reports for several years, including Best in KLAS in 2021, 2022, 2024, and 2025, and Micromedex in 2023 and 2026, it is evident that the collaboration between EBSCO and Merative sets a high standard in clinical support solutions.

The Journey to Recognition

The KLAS report is an annual evaluation that collates feedback from thousands of healthcare providers about their experiences with various vendors. As a renowned independent research company, KLAS focuses on assessing the quality and effectiveness of health information technology products. The rankings serve as vital benchmarks within the industry, reflecting direct insights from providers on how well these solutions contribute to better healthcare outcomes and adaptability in a fast-evolving landscape.

Roy Ziegelstein, M.D., MACP, Editor-in-Chief of DynaMed, emphasized the underlying mission of DynaMedex: "Our goal is to enhance patient experiences and outcomes at the point of care. This relies on absolute trust in the clinicians’ and technology’s capabilities. Our ongoing recognition by KLAS reinforces that our platform is a trusted clinical intelligence source across healthcare."

Supporting Healthcare Professionals

The integration of Dyna AI for DynaMedex is set to further accentuate DynaMedex’s capabilities. This upcoming enhancement will enrich the platform with expanded drug content, including comprehensive dosing and medication safety information derived from Micromedex. By continuous technological advancements and maintaining robust clinical resources, DynaMedex ensures that healthcare providers have the essential tools to make informed decisions when they matter most.

Adam Gale, CEO of KLAS Research, remarked on the importance of such awards, stating, "The Best in KLAS awards acknowledge the vendors that demonstrate consistent excellence through collaboration with healthcare organizations. Receiving this award reflects customer trust in your solution to help them maneuver through the dynamic healthcare landscape effectively."

A Commitment to Excellence

This latest accolade not only highlights the success of DynaMedex but also affirms EBSCO Information Services' ongoing commitment to revolutionizing point-of-care clinical decisions. The emphasis on providing rapid access to critical information reinforces the company's mission to support healthcare professionals and ultimately improve patient care.

For more information on the award-winning DynaMedex solution and the Best in KLAS report, healthcare organizations and professionals can visit the EBSCO website.

Conclusion

DynaMedex® stands tall in 2026 as a beacon of excellence in clinical decision support, enhancing the quality of health care and reaffirming its pivotal role in patient management. As EBSCO Information Services continues to innovate and expand its offerings, the healthcare community can anticipate even more advancements in clinical intelligence tools designed to empower clinicians and improve patient outcomes.